Prelude Therapeutics Incorporated (NASDAQ:PRLD) Insider Purchases $82,200.00 in Stock

Prelude Therapeutics Incorporated (NASDAQ:PRLD – Get Free Report) insider Andrew Combs purchased 60,000 shares of the stock in a transaction dated Monday, December 23rd. The shares were purchased at an average price of $1.37 per share, for a total transaction of $82,200.00. Following the completion of the transaction, the insider now owns 377,623 shares in […]

Leave a Reply

Your email address will not be published.

Previous post Scott Schatz Sells 5,000 Shares of Townsquare Media, Inc. (NYSE:TSQ) Stock
Next post Hamilton Lane Incorporated (NASDAQ:HLNE) Receives Consensus Recommendation of “Hold” from Brokerages